Zhong Y - Search Results

1

Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture.

Ju X, Yan Y, Liu Q, Li N, Sheng M, Zhang L, Li X, Liang Z, Huang F, Liu K, Zhao Y, Zhang Y, Zou Z, Du J, Zhong Y, Zhou H, Yang P, Lu H, Tian M, Li D, Zhang J, Jin N, Jiang C. Ju X, et al. Among authors: zhong y. J Virol. 2015 Oct;89(20):10347-58. doi: 10.1128/JVI.01411-15. Epub 2015 Aug 5. J Virol. 2015. PMID: 26246576 Free PMC article.

2

Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.

Miao R, Luo H, Zhou H, Li G, Bu D, Yang X, Zhao X, Zhang H, Liu S, Zhong Y, Zou Z, Zhao Y, Yu K, He L, Sang X, Zhong S, Huang J, Wu Y, Miksad RA, Robson SC, Jiang C, Zhao Y, Zhao H. Miao R, et al. Among authors: zhong s, zhong y. J Hepatol. 2014 Oct;61(4):840-9. doi: 10.1016/j.jhep.2014.05.025. Epub 2014 May 22. J Hepatol. 2014. PMID: 24859455

3

Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro.

Sheng M, Zhong Y, Chen Y, Du J, Ju X, Zhao C, Zhang G, Zhang L, Liu K, Yang N, Xie P, Li D, Zhang MQ, Jiang C. Sheng M, et al. Among authors: zhong y. Sci China Life Sci. 2014 Oct;57(10):959-72. doi: 10.1007/s11427-014-4742-y. Epub 2014 Sep 13. Sci China Life Sci. 2014. PMID: 25218824

4

Potential clinical treatment for Ebola pandemic.

Zhong Y, Xu J, Li T, Yu X, Sheng M. Zhong Y, et al. Sci China Life Sci. 2014 Oct;57(10):982-4. doi: 10.1007/s11427-014-4756-5. Epub 2014 Sep 19. Sci China Life Sci. 2014. PMID: 25239448 Free PMC article. No abstract available.

5

HER2 amplification level is not a prognostic factor for HER2-positive breast cancer with trastuzumab-based adjuvant treatment: a systematic review and meta-analysis.

Xu QQ, Pan B, Wang CJ, Zhou YD, Mao F, Lin Y, Guan JH, Shen SJ, Zhang XH, Xu YL, Zhong Y, Wang XJ, Zhang YN, Sun Q. Xu QQ, et al. Among authors: zhong y. Oncotarget. 2016 Sep 27;7(39):63571-63582. doi: 10.18632/oncotarget.11541. Oncotarget. 2016. PMID: 27566580 Free PMC article. Review.

6

[Diagnosis and treatment of occult breast cancer: report of 23 cases].

Zhong Y, Sun Q, Huang HY, Zhou YD, Guan JH, Mao F, Lin Y, Xu YL. Zhong Y, et al. Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):716-8. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122392 Chinese.

7

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.

Xu Q, Xu Y, Pan B, Wu L, Ren X, Zhou Y, Mao F, Lin Y, Guan J, Shen S, Zhang X, Wang C, Zhong Y, Zhou L, Liang Z, Zhao H, Sun Q. Xu Q, et al. Among authors: zhong y. Oncotarget. 2016 Dec 6;7(49):81815-81829. doi: 10.18632/oncotarget.13245. Oncotarget. 2016. PMID: 27833085 Free PMC article.

8

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells.

Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q. Zhong Y, et al. Onco Targets Ther. 2016 Nov 7;9:6865-6871. doi: 10.2147/OTT.S109606. eCollection 2016. Onco Targets Ther. 2016. PMID: 27853380 Free PMC article.

9

Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.

Zhong Y, Lin Y, Shen S, Zhou Y, Mao F, Guan J, Sun Q. Zhong Y, et al. Cancer Cell Int. 2013 Jun 15;13(1):60. doi: 10.1186/1475-2867-13-60. Cancer Cell Int. 2013. PMID: 23767668 Free PMC article.

10

ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.

Zhong Y, Shen S, Zhou Y, Mao F, Guan J, Lin Y, Xu Y, Sun Q. Zhong Y, et al. Med Oncol. 2014 Mar;31(3):864. doi: 10.1007/s12032-014-0864-0. Epub 2014 Feb 12. Med Oncol. 2014. PMID: 24519209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,763 results

Search Page